Table: Medipal Holdings -2023/24 group results
May 14 (Reuters)-
Medipal Holdings Corp
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2024 Mar 31, 2023 Mar 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 3.56 trln 3.36 trln 3.66 trln
(+5.9 pct) (+2.1 pct) (+2.8 pct)
Operating 47.33 48.97 50.00
(-3.4 pct) (+7.3 pct) (+5.6 pct)
Recurring 64.57 65.12 66.00
(-0.8 pct) (+5.0 pct) (+2.2 pct)
Net
Net 41.47 38.81 33.50
(+6.9 pct) (+31.9 pct) (-19.2 pct)
EPS 195.83 yen 184.82 yen 160.87 yen
EPS Diluted 179.12 yen
Ann Div 60.00 yen 46.00 yen 60.00 yen
-Q2 Div 30.00 yen 23.00 yen 30.00 yen
-Q4 Div 30.00 yen 23.00 yen 30.00 yen
NOTE - Medipal Holdings Corp.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7459.T
Recent news on Medipal Holdings
See all newsBrief: Medipal Holdings Corp Says It Will Buy Back Up To 2% Of Own Shares Worth 10 Billion Yen
Table: Medipal Holdings -2026/27 group forecast
Brief: Medipal Holdings Announces It Has Received Demand For EGM From Shareholder Silchester International Investors
Brief: Silchester International Raises Stake In Medipal Holdings Corp To 11.96% From 11.73%, Filing Shows
Brief: Silchester To Make Proposals Regarding Higher Dividend, Share Buyback, Share Retirement, Composition Of Board Of Directors If No Improvement In Dialogue With Medipal Holdings, Filing Shows